José holds a PhD in Neuroscience from Universidade of Porto, in Portugal. He has also studied Biochemistry at Universidade do Porto and was a postdoctoral associate at Weill Cornell Medicine, in New York, and at The University of Western Ontario in London, Ontario, Canada. His work has ranged from the association of central cardiovascular and pain control to the neurobiological basis of hypertension, and the molecular pathways driving Alzheimer’s disease.
Having interstitial lung disease (ILD) is associated with a greater risk of lung cancer in scleroderma patients, according to Canadian researchers. Their findings also demonstrate that male sex and ... Read more
Nailfold capillary damage was found to be a predictor of mortality in scleroderma patients, according to researchers from Australia. The study, “The role of Nailfold Capillary Dropout on Mortality ... Read more
Major healthcare organizations are throwing their support behind an initiative called “Let MI Doctors Decide” intended to improve patient access to prescribed medicines for scleroderma and other autoimmune disorders ... Read more
Throughout 2018, Scleroderma News provided daily coverage of treatment developments, clinical trials, risk factors, and non-pharmacological approaches related to scleroderma. As we look forward to reporting more news to ... Read more
Restoring the activity of the protein adiponectin ameliorates skin fibrosis in mouse models of scleroderma, a new study shows. The study, “Adiponectin is an endogenous anti-fibrotic mediator and therapeutic ... Read more
Skin levels of aquaporin 3 (AQP3), a protein which promotes skin hydration and wound healing, are reduced in the cells of patients with systemic sclerosis (SSc), according to a ... Read more
Pin It on Pinterest